Eisner Mark sold VIR
February 25, 2026 · Form 4 insider transaction
Eisner Mark sold 1,889 shares of Vir Biotechnology, Inc. at $9.82 per share, a transaction worth $18.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,889
Price
$9.82
Total value
$18.5K
InsiderEisner Mark
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 25, 2026
Filing dateFebruary 26, 2026
Shares owned after154,024
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.